Current Research & Innovations

Kidney Cancer

• Renal Cell Cancer Treatment: Evaluating TroVax in Conjunction with Interleukin-2 (IL-2) —A preliminary study of the safety, immunogenicity, and clinical efficacy of TroVax given in conjunction with Interleukin-2 (IL-2) in the treatment of stage IV renal cell cancer. (Howard Kaufman, MD)